Sign In
Buy AGN
$193.02
+0 (+0%)
At Close: Sep 04, 2020
LOS ANGELES--(BUSINESS WIRE)---- $AGN #AGN--INVESTIGATION ALERT: The Schall Law Firm Announces it is Investigating Claims Against Allergan plc.
Los Angeles, California--(Newsfile Corp. - October 26, 2020) - The Schall Law Firm, a national shareholder rights litigation firm, announces the filing of a class action lawsuit against Allergan plc (
AGN-151587 (EDIT-101) is the first in vivo CRISPR medicine to be administered to patients
Allergan Reports Q4 Earnings Beat
12:00am, Monday, 10'th Feb 2020
Allergan plc (NYSE: AGN) reported quarterly earnings of $5.22 per share on Monday, beating the analyst consensus estimate of $4.57 by 14.22%.
This is a 21.68% increase over...
Allergan Announces Quarterly Conference Call
01:00pm, Friday, 24'th Oct 2014
IRVINE, Calif.--(BUSINESS WIRE)--Allergan, Inc. (NYSE: AGN) invites you to listen to David Pyott, Chairman of the Board and Chief Executive Officer, and Jim Hindman, Executive Vice President, Finance
Allergan Announces Quarterly Conference Call
12:00pm, Friday, 18'th Jul 2014
IRVINE, Calif.--(BUSINESS WIRE)--Allergan, Inc. (NYSE: AGN) invites you to listen to David Pyott, Chairman of the Board and Chief Executive Officer, and Jeff Edwards, Executive Vice President, Finance
Allergan Announces Quarterly Conference Call
05:30pm, Friday, 04'th Apr 2014
IRVINE, Calif.--(BUSINESS WIRE)--Allergan, Inc. (NYSE: AGN) invites you to listen to David Pyott, Chairman of the Board and Chief Executive Officer, and Jeff Edwards, Executive Vice President, Finance
